$TMBR Timber Pharmaceuticals is the play of the we
Post# of 10
Today Aug. 29th, 2022 news:
Timber Pharmaceuticals to Highlight Phase 2b CONTROL Study Results in Multiple Presentations at 31st EADV Congress
New from Aug. 26, 2022:
Timber Pharmaceuticals Announces Publication of Results from Phase 2b CONTROL Study of FDA-Designated Breakthrough Therapy TMB-001 in the Journal of the American Academy of Dermatology
Lots of potential here and coming off a 52 week low. This could hit a $1.00 fast and is part of the NYSE. Good luck to all.
EliteStockPicks